Biotech AMGEN ANNOUNCES POSITIVE PHASE 3 RESULTS FOR DAZODALIBEP IN SJÖGREN’S DISEASE November 12, 2026
Biotech Research Solutions Announces Agreement With Fortune 500 Biopharma Company Valued at $1 Million November 12, 2026
Biotech Citius Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London November 12, 2026
Biotech Castle Biosciences to Present at the Piper Sandler 38th Annual Healthcare Conference November 11, 2026
Biotech Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update November 11, 2026